I. Membrive

Hospital Del Mar — Spain

Biochemistry, Genetics and Molecular Biology · Life Sciences

13h-index833citations80works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Breast Cancer Treatment Studies(21), Advanced Radiotherapy Techniques(14), Nonmelanoma Skin Cancer Studies(14), Effects of Radiation Exposure(10), Lung Cancer Diagnosis and Treatment(9)

Publications80 total

1434: Clinical utility and impact on the therapeutic management of PET 18F-PSMA DCFPyL in prostate cancer
Radiotherapy and Oncology·2024
1444: Diagnostic capacity of 18F-PSMA DCFPyL in biochemical relapse of prostate cancer with low PSA values
Radiotherapy and Oncology·2024
958 Impact of the integration of the molecular classification of endometrial cancer on risk stratification of endometrial carcinomas: our institution experience, A 131 case series
2024
Diagnostic Utility of PSMA 18F-DCFPyL PET/TC in Occult Biochemical Recurrence of Prostate Carcinoma with PSA Values <2ng/ml More than Two Years of Experience
International Journal of Radiation Oncology*Biology*Physics·2023Open Access
Change in Therapeutic Approach after PET/TC PSMA-18F DCFPyL in Occult Biochemical Recurrence of Prostate Carcinoma with Low PSA Values
International Journal of Radiation Oncology*Biology*Physics·2023Open Access
A Phase II Trial of Intraoperative Radiotherapy after Surgical Resection of Brain Metastases: Feasibility and Efficacy NCT04847284
International Journal of Radiation Oncology*Biology*Physics·2023· 1 citedOpen Access
Impact of Lymphopenia on Treatment Outcomes in Unresectable Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics·2023Open Access
#1032 Addressing women’s sexual health after gynecological cancer primary treatment
2023Open Access
P145 - CAMBIO DE LA ACTITUD TERAPÉUTICA TRAS PET/TC 18F-DCFPYL EN LA RECIDIVA BIOQUÍMICA OCULTA DEL CARCINOMA DE PRÓSTATA CON VALORES BAJOS DE PSA
Revista Española de Medicina Nuclear e Imagen Molecular·2023
P144 - UTILIDAD DIAGNÓSTICA DEL 18F-DCFPY L PET/TC EN RECIDIVA BIOQUÍMICA OCULTA DEL CARCINOMA DE PRÓSTATA CON VALORES DE PSA < 2NG/ML. MAS DE DOS AÑOS DE EXPERIENCIA EN USO COMPASIVO
Revista Española de Medicina Nuclear e Imagen Molecular·2023
Low photon intraoperative irradiation as anticipated boost in early breast cancer followed by risk adapted moderate daily hipofractionated whole breast irradiation
European Journal of Surgical Oncology·2023
Management of high-risk and post-operative non-metastatic prostate cancer in Catalonia: an expert Delphi consensus
Clinical & Translational Oncology·2022· 2 cited
Machine learning-based automated planning for hippocampal avoidance prophylactic cranial irradiation
Clinical & Translational Oncology·2022· 4 cited
Quantitative assessments of late radiation-induced skin and soft tissue toxicity and correlation with RTOG scales and biological equivalent dose in breast cancer
Clinical & Translational Oncology·2021· 9 citedOpen Access
High-dose-rate plesiotherapy with customized molds in non-melanoma skin cancer: efficacy and safety at 10 years—single institution experience
Clinical & Translational Oncology·2021· 4 citedOpen Access
Validation of 3D printing materials for high dose-rate brachytherapy using ionisation chamber and custom phantom
Physics in Medicine and Biology·2021· 5 cited
Custom 3D-printed applicators for high dose-rate brachytherapy in skin cancer
Brachytherapy·2021· 15 cited
Determination of the optimal range for virtual monoenergetic images in dual‐energy CT based on physical quality parameters
Medical Physics·2021· 2 cited
Could pulmonary low-dose radiation therapy be an alternative treatment for patients with COVID-19 pneumonia? Preliminary results of a multicenter SEOR-GICOR nonrandomized prospective trial (IPACOVID trial)
Strahlentherapie und Onkologie·2021· 27 citedOpen Access
P-93 A case of peritoneal carcinomatosis after hyperprogression in HPV+ oropharyngeal squamous cell carcinoma
Oral Oncology·2021
page 1 of 4Next →

Frequent Co-authors

P. Foro(45), M. Algara(43), Núria Rodríguez(38), J. Lozano(21), E. Fernández-Velilla(21), X. Sanz(19), A. Reig(17), J. Quera(17), O. Pera(12), A. Reig(12), J. Sanz(11), M. Lacruz(8), Xavier Sanz Latiesas(7), Min Zhao(6), Alvaro A. Martinez(6), J. Dengra(5), A. Reig Castillejo(5), Anna Reig Castillejo(4), Martí Lacruz Bassols(4), A. Ortiz(4)